Sartorius AG Xetra

Equities

SRT

DE0007165607

Advanced Medical Equipment & Technology

Market Closed - Xetra 11:44:17 2024-04-18 am EDT After market 03:59:50 pm
209 EUR -15.90% Intraday chart for Sartorius AG 212 +1.44%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
German Shares Close Green as Bundesbank Sees Q1 Economic Growth MT
SARTORIUS VORZUEGE : Barclays remains Neutral ZD
FTSE 100 up despite hawkish Fed rates outlook AN
Transcript : Sartorius Aktiengesellschaft, Q1 2024 Earnings Call, Apr 18, 2024
Sartorius continues recovery after weak start - share price slide DP
SARTORIUS VORZUEGE : Warburg Research reiterates its Neutral rating ZD
Sartorius Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Sartorius and subsidiary Stedim under pressure after weak figures DP
SARTORIUS VORZUEGE : Jefferies remains Neutral ZD
SARTORIUS VORZUEGE : Berenberg reiterates its Buy rating ZD
UBS rates Sartorius 'Neutral' - Target 366 euros DP
SARTORIUS VORZUEGE : JP Morgan reaffirms its Buy rating ZD
SARTORIUS VORZUEGE : UBS sticks Neutral ZD
Sartorius Posts Lower Q1 Attributable Profit, Sales Revenue MT
Sartorius gets off to a slow start to the year - still hoping for recovery DP
SARTORIUS VORZUEGE : UBS sticks Neutral ZD
Correction: Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience MT
Germany’s Sartorius Strikes Partnership with US-based TheWell Bioscience MT
SARTORIUS VORZUEGE : Barclays reaffirms its Neutral rating ZD
Transcript : Sartorius Aktiengesellschaft - Shareholder/Analyst Call
SARTORIUS VORZUEGE : JP Morgan maintains a Buy rating ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral ZD
Stifel reinstates Sartorius with 'Buy' - target 415 euros DP
SARTORIUS VORZUEGE : UBS reiterates its Neutral rating ZD
SARTORIUS VORZUEGE : Jefferies sticks Neutral ZD
Chart Sartorius AG
More charts
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
329.7 EUR
Average target price
352.3 EUR
Spread / Average Target
+6.86%
Consensus
  1. Stock Market
  2. Equities
  3. SRT3 Stock
  4. SRT Stock
  5. News Sartorius AG
  6. Sartorius : Lifts Sales Outlook for FY21 Amid High Orders, Stable Supply Chain